CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY - USD ($) shares in Millions, $ in Millions	Total	Common stock:	Additional paid-in-capital:	Treasury stock at cost:	Retained earnings:	Accumulated other comprehensive income:
Balance, beginning of year at Dec. 31, 2022		$ 2	$ 17,279	$ (46,702)	$ 34,315	$ 259
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common stock repurchased				(1,412)
Common stock and stock-based awards issued			83
Tax withholdings related to net share settlements of restricted stock awards and units			(161)
Stock-based compensation			575
Other			16
Net income	$ 2,767				2,767
Dividends and dividend equivalents declared					(551)
Change in unrealized gains on investments	53					53
Change in unrealized gains (losses) on derivative instruments						(127)
Foreign currency translation adjustment						(16)
Tax benefit (provision) on above items						16
Balance, end of year at Dec. 31, 2023	$ 6,396	$ 2	17,792	(48,114)	36,531	185
Common stock, beginning of year (in shares) at Dec. 31, 2022		539
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common stock issued (in shares)		10
Common stock repurchased (in shares)		(32)
Common stock, end of period (in shares) at Dec. 31, 2023		517
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Dividends and dividend equivalents declared per share or restricted stock unit (in usd per share)	$ 1.00
Common stock repurchased				(3,176)
Common stock and stock-based awards issued			87
Tax withholdings related to net share settlements of restricted stock awards and units			(199)
Stock-based compensation			590
Other			19
Net income	$ 1,975				1,975
Dividends and dividend equivalents declared					(555)
Change in unrealized gains on investments	38					38
Change in unrealized gains (losses) on derivative instruments						88
Foreign currency translation adjustment						(76)
Tax benefit (provision) on above items						(29)
Balance, end of year at Dec. 31, 2024	$ 5,158	$ 2	18,289	(51,290)	37,951	206
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common stock issued (in shares)		10
Common stock repurchased (in shares)		(56)
Common stock, end of period (in shares) at Dec. 31, 2024	471	471
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Dividends and dividend equivalents declared per share or restricted stock unit (in usd per share)	$ 1.08
Common stock repurchased	$ (2,500)			(2,517)
Common stock and stock-based awards issued			141
Tax withholdings related to net share settlements of restricted stock awards and units			(274)
Stock-based compensation			610
Other			19
Net income	2,031				2,031
Dividends and dividend equivalents declared					(554)
Change in unrealized gains on investments	24					24
Change in unrealized gains (losses) on derivative instruments						(82)
Foreign currency translation adjustment						48
Tax benefit (provision) on above items						11
Balance, end of year at Dec. 31, 2025	$ 4,615	$ 2	$ 18,785	$ (53,807)	$ 39,428	$ 207
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common stock issued (in shares)		11
Common stock repurchased (in shares)	(33)	(33)
Common stock, end of period (in shares) at Dec. 31, 2025	449	449
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Dividends and dividend equivalents declared per share or restricted stock unit (in usd per share)	$ 1.16

EBAY INC 10-K